Liu & colleagues [60] suggested that decreasing or abolishing the activity of the CYP2A6 by means of specific inhibitors might prevent the frequency of occurrence of tobacco-induced lung cancer in smokers only. The gene discussed is CYP2A6; the disease is lung carcinoma.